Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Sep;60(9):1067-8.
doi: 10.1136/jcp.2006.043356. Epub 2007 Feb 9.

Chromogenic in situ hybridisation (CISH) should be an accepted method in the routine diagnostic evaluation of HER2 status in breast cancer

S Di Palma  1 , N Collins, C Faulkes, B Ping, G Ferns, B Haagsma, G Layer, M W Kissin, M G Cook
Affiliations

Chromogenic in situ hybridisation (CISH) should be an accepted method in the routine diagnostic evaluation of HER2 status in breast cancer

S Di Palma et al. J Clin Pathol. 2007 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: none declared.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ellis I O, Bartlett J, Dowsett M.et al Best Practice No 176: Updated recommendations for HER2 testing in the UK. J Clin Pathol 200457233–237. - PMC - PubMed
    1. Slamon D J, Leyland‐Jones B, Shak S.et al Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001344783–792. - PubMed
    1. Saez A, Andreu F A, Segui M A.et al HER‐2 gene amplification by chromogenic in situ hybridisation (CISH) compared with fluorescence in situ hybridisation (FISH) in breast cancer—a study of two hundred cases. Breast 200615519–527. - PubMed
    1. Pauletti G, Dandekar S, Rong H.et al Assessment of methods for tissue‐based detection of the HER‐2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry. J Clin Oncol 2000183651–3664. - PubMed
    1. Gong Y, Gilcrease M, Sneige N. Reliability of chromogenic in situ hybridization for detecting HER‐2 gene status in breast cancer: comparison with fluorescence in situ hybridization and assessment of interobserver reproducibility. Mod Pathol 2005181015–1021. - PubMed

Publication types

MeSH terms